Lykos’ psychedelic-assisted therapy model was meant to reinvent mental healthcare as we know it. Its PTSD protocol, which included preparation support, three guided MDMA therapy sessions, and integration counseling, took a bold step toward merging pharmacology with psychotherapy. But the FDA’s decision to reject it may force the psychedelic industry to pivot from resource-intensive and […]
The post Is Psychedelic-Assisted Therapy at a Crossroads? Exploring What’s Next for Lykos & MDMA Treatment appeared first on Psychedelics Today.
